C114H132F15N37O8S2 — CID 158413262
6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-yl-N-[6-(1-propan-2-ylpiperidin-4-yl)oxy-3-pyridinyl]pyrimidin-4-amine;N-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-4-[2-(diethylamino)ethyl]-1,3-thiazol-2-amine;N-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-5-(diethylaminomethyl)-1,3-thiazol-2-amine;1-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-3-phenylimidazolidin-2-one;1-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]piperidin-2-one (PubChem CID 158413262) has the molecular formula C114H132F15N37O8S2 and a molecular weight of 2497.66 g/mol. Its IUPAC name is 6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-yl-N-[6-(1-propan-2-ylpiperidin-4-yl)oxy-3-pyridinyl]pyrimidin-4-amine;N-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-4-[2-(diethylamino)ethyl]-1,3-thiazol-2-amine;N-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-5-(diethylaminomethyl)-1,3-thiazol-2-amine;1-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-3-phenylimidazolidin-2-one;1-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]piperidin-2-one.
| Compound Name | 6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-yl-N-[6-(1-propan-2-ylpiperidin-4-yl)oxy-3-pyridinyl]pyrimidin-4-amine;N-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-4-[2-(diethylamino)ethyl]-1,3-thiazol-2-amine;N-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-5-(diethylaminomethyl)-1,3-thiazol-2-amine;1-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-3-phenylimidazolidin-2-one;1-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]piperidin-2-one |
|---|---|
| PubChem CID | 158413262 |
| Molecular Formula | C114H132F15N37O8S2 |
| Molecular Weight | 2497.66 g/mol |
| Exact Mass | 2496.03 |
| IUPAC Name | 6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-yl-N-[6-(1-propan-2-ylpiperidin-4-yl)oxy-3-pyridinyl]pyrimidin-4-amine;N-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-4-[2-(diethylamino)ethyl]-1,3-thiazol-2-amine;N-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-5-(diethylaminomethyl)-1,3-thiazol-2-amine;1-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]-3-phenylimidazolidin-2-one;1-[6-[6-amino-4-(trifluoromethyl)-3-pyridinyl]-2-morpholin-4-ylpyrimidin-4-yl]piperidin-2-one |
| SMILES | CC(C)N1CCC(Oc2ccc(Nc3cc(-c4cnc(N)cc4C(F)(F)F)nc(N4CCOCC4)n3)cn2)CC1.CCN(CC)CCc1csc(Nc2cc(-c3cnc(N)cc3C(F)(F)F)nc(N3CCOCC3)n2)n1.CCN(CC)Cc1cnc(Nc2cc(-c3cnc(N)cc3C(F)(F)F)nc(N3CCOCC3)n2)s1.Nc1cc(C(F)(F)F)c(-c2cc(N3CCCCC3=O)nc(N3CCOCC3)n2)cn1.Nc1cc(C(F)(F)F)c(-c2cc(N3CCN(c4ccccc4)C3=O)nc(N3CCOCC3)n2)cn1 |
| InChI | InChI=1S/C27H33F3N8O2.C23H29F3N8OS.C23H22F3N7O2.C22H27F3N8OS.C19H21F3N6O2/c1-17(2)37-7-5-19(6-8-37)40-25-4-3-18(15-33-25)34-24-14-22(35-26(36-24)38-9-11-39-12-10-38)20-16-32-23(31)13-21(20)27(28,29)30;1-3-33(4-2)6-5-15-14-36-22(29-15)32-20-12-18(30-21(31-20)34-7-9-35-10-8-34)16-13-28-19(27)11-17(16)23(24,25)26;24-23(25,26)17-12-19(27)28-14-16(17)18-13-20(30-21(29-18)31-8-10-35-11-9-31)33-7-6-32(22(33)34)15-4-2-1-3-5-15;1-3-32(4-2)13-14-11-28-21(35-14)31-19-10-17(29-20(30-19)33-5-7-34-8-6-33)15-12-27-18(26)9-16(15)22(23,24)25;20-19(21,22)13-9-15(23)24-11-12(13)14-10-16(28-4-2-1-3-17(28)29)26-18(25-14)27-5-7-30-8-6-27/h3-4,13-17,19H,5-12H2,1-2H3,(H2,31,32)(H,34,35,36);11-14H,3-10H2,1-2H3,(H2,27,28)(H,29,30,31,32);1-5,12-14H,6-11H2,(H2,27,28);9-12H,3-8,13H2,1-2H3,(H2,26,27)(H,28,29,30,31);9-11H,1-8H2,(H2,23,24) |
| InChIKey | GZONFQUUZTWGGH-UHFFFAOYSA-N |
| XLogP | 18.36 |
| TPSA | 523.37 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 44 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 176 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2497.66 |
| LogP ≤ 5 | 18.36 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 44 |